1.44 - 1.45
1.18 - 2.36
89.1K / 1.73M (Avg.)
-18.12 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
100.00%
Positive revenue growth while 1097.HK is negative. John Neff might see a notable competitive edge here.
-100.00%
Negative gross profit growth while 1097.HK is at 22.19%. Joel Greenblatt would examine cost competitiveness or demand decline.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative operating income growth while 1097.HK is at 32.91%. Joel Greenblatt would press for urgent turnaround measures.
-100.00%
Negative net income growth while 1097.HK stands at 38.24%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-101.92%
Negative EPS growth while 1097.HK is at 37.92%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-101.92%
Negative diluted EPS growth while 1097.HK is at 38.14%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-89.25%
Dividend reduction while 1097.HK stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-309.88%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-54.96%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-99.58%
Negative 10Y revenue/share CAGR while 1097.HK stands at 56.98%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-99.16%
Negative 5Y CAGR while 1097.HK stands at 61.31%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-99.62%
Negative 3Y CAGR while 1097.HK stands at 67.38%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-173.07%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-178.15%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-168.71%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-105.22%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-127.49%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-106.83%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
536.80%
Stable or rising dividend while 1097.HK is cutting. John Neff sees a strong advantage in consistent shareholder returns vs. a struggling peer.
988.65%
Stable or rising mid-term dividends while 1097.HK is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
33.80%
Our short-term dividend growth is positive while 1097.HK cut theirs. John Neff views it as a comparative advantage in shareholder returns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-56.95%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.